PTK2 and cancer: Specific cell survival pathways in cancers become activated to promote cell survival, such as the FAK/Src pathway, which is closely involved in cell cycle progression and proliferation in that FAK signaling can lead to increased cyclin D1 expression, a key regulator of the G1 to S phase transition [11].